EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The characteristics of methicillin-resistant Staphylococcus aureus co-infection in COVID-19 pneumonia

Feifei Gu, Yuyi Zhang, Jingyong Sun, Wei Guo, Lizhong Han

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1560688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Feifei Gu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, COVID-19, Coinfection, Staphylococcal Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus (MRSA) stands as a pervasive and important pathogen in the co-infections during the COVID-19 pandemic given its high morbidity and mortality. This study aimed to characterize MRSA isolates obtained from COVID-19 pneumonia with MRSA co-infection patients during the COVID-19 pandemic wave in China from 2022 to 2024. Fifty MRSA isolates collected form COVID-19 pneumonia with MRSA co-infection patients (MRSA-COC) and 50 MRSA isolates collected from MRSA pneumonia patients without COVID-19 (MRSA-CON) were enrolled in this study. Whole-genome sequencing, genomic epidemiology and comparative analysis were conducted to explore differences of MRSA isolates between two groups. Patients with MRSA-COC were significantly older ( P =0.0492), had higher rates of severe pneumonia progression ( P =0.0006), and carried greater comorbidity burdens. The time from hospital admission to MRSA detected was significantly shorter in MRSA-COC patients than in MRSA-CON patients ( P =0.0141). Furthermore, MRSA-COC patients demonstrated significantly higher mortality rates compared with MRSA-CON patients (44% vs. 18%, P =0.0049). However, genomic analysis revealed no statistically significant differences in antimicrobial resistance gene or virulence factor genes between the MRSA-COC and MRSA-CON isolates. CC5 emerged as the predominant clone in both groups, with significantly higher prevalence in MRSA-COC isolates (88% vs. 66%, P =0.0090). The tst -positive ST5-MRSA-II strain was associated with concerning mortality rates in both MRSA-COC (50%) and MRSA-CON (20%) patients, underscoring the critical need for enhanced surveillance in MRSA pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusCOVID-19CoinfectionStaphylococcal InfectionsPneumonia, StaphylococcalHumansMaleFemaleMiddle AgedAgedChinaSARS-CoV-2Whole Genome SequencingAdultAnti-Bacterial AgentsAged, 80 and over

Stichwörter der Autor:innen

COVID-19MRSASARS-CoV-2Staphylococcus aureusco-infection

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Zitieren

APA

Gu, F., Zhang, Y., Sun, J., Guo, W., & Han, L. (2025). The characteristics of methicillin-resistant Staphylococcus aureus co-infection in COVID-19 pneumonia. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1560688

Vancouver

Gu F, Zhang Y, Sun J, Guo W, Han L. The characteristics of methicillin-resistant Staphylococcus aureus co-infection in COVID-19 pneumonia. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1560688

BibTeX
@article{Gu2025,
  author = {Gu, Feifei and Zhang, Yuyi and Sun, Jingyong and Guo, Wei and Han, Lizhong},
  title = {The characteristics of methicillin-resistant Staphylococcus aureus co-infection in COVID-19 pneumonia},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1560688}
}
Kostenlos starten →